摘要
Abstract
OBJECTIVE:To study the effects of pharmaceutical corporate social responsibility (PCSR) on corporate competitiveness (CC).METHODS:Supposing that PCSR had significant effect on CC,and then pharmaceutical corporation also had effect on shareholders,creditors,staff,suppliers,consumer and government.Social responsibility index of 42 pharmaceutical listed companies were collected during 2003-2010 to establish one-linear regression model,such as earning per share,employee benefits; and empirical analysis and hypothesis verification were performed with factor analysis method to discuss the effects of social responsibility index on CC index,such as sales income,net asset.RESULTS:The model setting was reasonable,and the following assumptions was verified:firstly,there was positive relationship between PCSR and CC,with regression coefficient of 1.304;secondly,there was positive relationship between PCSR performed for shareholders,creditors,suppliers and CC,with regression coefficient of 0.211,0.176 and 0.767; thirdly,there was no significant relationship between PCSR performed for staff,consumer,government and CC,with regression coefficient of-0.029,-0.044 and-0.015.CONCLUSIONS:Pharmaceutical corporations should perform social responsibility actively to improve CC.关键词
企业社会责任/企业竞争力/利益相关者/实证研究Key words
Corporate social responsibility/Corporate competitiveness/Stakeholders/Empirical study分类
医药卫生
